These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17107724)

  • 21. IL-6 and its receptors in coronary artery disease and acute myocardial infarction.
    Anderson DR; Poterucha JT; Mikuls TR; Duryee MJ; Garvin RP; Klassen LW; Shurmur SW; Thiele GM
    Cytokine; 2013 Jun; 62(3):395-400. PubMed ID: 23582716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weight loss in obesity reduces epicardial fat thickness; so what?
    Sacks HS
    J Appl Physiol (1985); 2009 Jan; 106(1):1-2. PubMed ID: 18948441
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue.
    Fain JN; Madan AK
    Int J Obes (Lond); 2005 Nov; 29(11):1299-307. PubMed ID: 15997242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epicardial adipose tissue and insulin resistance in obese subjects.
    Iacobellis G; Leonetti F
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6300-2. PubMed ID: 16091479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Echocardiographic epicardial fat: a review of research and clinical applications.
    Iacobellis G; Willens HJ
    J Am Soc Echocardiogr; 2009 Dec; 22(12):1311-9; quiz 1417-8. PubMed ID: 19944955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder.
    Mehra R; Storfer-Isser A; Kirchner HL; Johnson N; Jenny N; Tracy RP; Redline S
    Arch Intern Med; 2006 Sep; 166(16):1725-31. PubMed ID: 16983050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An association study between epicardial fat thickness and cognitive impairment in the elderly.
    Mazzoccoli G; Dagostino MP; Vinciguerra M; Ciccone F; Paroni G; Seripa D; Addante F; Montella RC; De Cosmo S; Sera F; Greco A
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(9):H1269-76. PubMed ID: 25172902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.
    Bruun JM; Lihn AS; Pedersen SB; Richelsen B
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2282-9. PubMed ID: 15671098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation.
    Kirovski G; Dorn C; Huber H; Moleda L; Niessen C; Wobser H; Schacherer D; Buechler C; Wiest R; Hellerbrand C
    Exp Mol Pathol; 2011 Dec; 91(3):780-3. PubMed ID: 21855538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
    Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation.
    Abbara S; Desai JC; Cury RC; Butler J; Nieman K; Reddy V
    Eur J Radiol; 2006 Mar; 57(3):417-22. PubMed ID: 16434161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated serum IL-6, IL-8, MCP-1, CRP, and IFN-γ levels in 10- to 11-year-old boys with increased BMI.
    Utsal L; Tillmann V; Zilmer M; Mäestu J; Purge P; Jürimäe J; Saar M; Lätt E; Maasalu K; Jürimäe T
    Horm Res Paediatr; 2012; 78(1):31-9. PubMed ID: 22832157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
    Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
    Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice.
    Tateya S; Tamori Y; Kawaguchi T; Kanda H; Kasuga M
    Endocrinology; 2010 Mar; 151(3):971-9. PubMed ID: 20056828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation.
    Sindhu S; Thomas R; Shihab P; Sriraman D; Behbehani K; Ahmad R
    PLoS One; 2015; 10(7):e0133494. PubMed ID: 26200663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients.
    Memoli B; Postiglione L; Cianciaruso B; Bisesti V; Cimmaruta C; Marzano L; Minutolo R; Cuomo V; Guida B; Andreucci M; Rossi G
    Kidney Int; 2000 Jul; 58(1):417-24. PubMed ID: 10886590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reply to "The role of soluble interleukin-6 receptor in inflammatory diseases" [Immunol Lett 2005;98(1):171].
    Michalopoulou M; Nikolaou C; Chatzipanagiotou S; Cambouri C; Tavernarakis A; Alexandri NM; Rentzos M; Vassilopoulos D
    Immunol Lett; 2006 May; 105(1):99. PubMed ID: 16564095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.